Byakangelicol (C007B-335734)

Byakangelicol, isolated from Angelica dahurica , inhibits interleukin-1beta (IL-1beta) -induced prostaglandin E2 (PGE2) release in A549 cells mediated by suppression of cyclooxygenase-2 (COX-2) expression and the activity of COX-2 enzyme. Byakangelicol has therapeutic potential as an anti-inflammatory agent on airway inflammationForm:SolidIC50& Target:COX-2. Specification: 0.99 Molecular Formula: C17H16O6 Molecular Weight: 316.3 EC Number: 866-350-9, 683-173-0 PubChem CID: 3055167 Isomeric SMILES: CC1([C@H](O1)COC2=C3C(=C(C4=C2OC(=O)C=C4)OC)C=CO3)C

UPC:

51461528

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

B646694-20mg

CAS:

26091-79-2

Product Size:

20mg